Abstract
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely use......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
